Beginner's Guide to Peptide Therapy

Peptide therapy is one of the fastest-growing areas in medicine, and also one of the most confusing. Scroll through health forums or biohacking communities and you will find people talking about BPC-157 for gut healing, semaglutide for weight loss, and CJC-1295/Ipamorelin for growth hormone optimization — often with wildly different opinions about legality, safety, and effectiveness. Some of these peptides are FDA-approved drugs prescribed by millions of doctors. Others exist in a regulatory gray zone. And a few are outright prohibited for human use by compounding pharmacies.

If you are new to this world, the sheer volume of information (and misinformation) can feel overwhelming. This guide gives you the full picture — what peptides are, the major categories, which ones are FDA-approved, how they are administered, what the current legal situation looks like, and what you should expect if you decide to explore peptide therapy with a qualified provider.

What Are Peptides?
Peptides vs. Proteins vs. Amino Acids: The Key Differences
How Do Peptides Work in the Body?
The Major Categories of Therapeutic Peptides
FDA-Approved Peptides: What is Already Mainstream
Compounded Peptides: The Gray Zone
Peptides That Are Prohibited from Compounding
How Peptides Are Administered
Finding a Qualified Peptide Therapy Provider
What to Expect When Starting Peptide Therapy
Safety, Side Effects, and Realistic Expectations
Peptide Storage and Handling Basics
The Legal Status of Peptides in 2025-2026
Common Myths and Misconceptions
Frequently Asked Questions
The Bottom Line
References

What Are Peptides?

Peptides are short chains of amino acids — the same building blocks that make up every protein in your body. The difference between a peptide and a protein is mainly size. A peptide is typically defined as a chain of 2 to 40 amino acids. Anything longer than 40 amino acids is generally classified as a protein.

Your body produces hundreds of natural peptides that regulate nearly every biological process. Insulin, which controls blood sugar, is a peptide hormone. Oxytocin, which governs social bonding and uterine contractions, is a peptide. Endorphins, your body's natural painkillers, are peptides. Growth hormone-releasing hormone (GHRH), which tells your pituitary gland to produce growth hormone, is a peptide.

Peptide therapy uses synthetic versions of these natural peptides — or entirely novel peptides designed to mimic specific biological functions — to address health conditions, support recovery, or optimize physiological processes.

Peptides vs. Proteins vs. Amino Acids: The Key Differences

Feature	Amino Acids	Peptides	Proteins
Size	Single molecules	2-40 amino acids	40+ amino acids
Examples	Glycine, leucine, tryptophan	Insulin, BPC-157, GHK-Cu	Collagen, hemoglobin, albumin
Function	Building blocks	Signaling molecules, hormones	Structural, enzymatic, transport
Absorption	Easily absorbed	Size-dependent; smaller peptides absorb better	Must be broken down before absorption
Regulation	Dietary supplements	Varies: drug, supplement, or research chemical	Generally food or drug

The 40-amino-acid cutoff matters for regulation. Under the Biologics Price Competition and Innovation Act, molecules with more than 40 amino acids are classified as biologics, which face stricter manufacturing and approval requirements. Shorter peptides are regulated as drugs, which have a somewhat different (though still rigorous) approval pathway.

How Do Peptides Work in the Body?

Peptides work primarily as signaling molecules. They bind to specific receptors on cell surfaces and trigger a cascade of biological responses. Think of them as keys that fit particular locks. Different peptides open different locks, producing different effects.

Growth hormone secretagogues like CJC-1295 and ipamorelin bind to receptors in the pituitary gland, signaling it to release growth hormone. Growth hormone then drives a cascade of effects throughout the body — increased muscle synthesis, fat metabolism, bone density, and cellular repair.

GLP-1 receptor agonists like semaglutide bind to GLP-1 receptors in the pancreas and brain. In the pancreas, they stimulate insulin release when blood sugar is high. In the brain, they reduce appetite and slow gastric emptying, producing the weight-loss effect that has made drugs like Ozempic and Wegovy household names.

Tissue-repair peptides like BPC-157 are thought to work through multiple mechanisms — promoting angiogenesis (new blood vessel growth), modulating inflammatory signaling, and potentially interacting with the nitric oxide system. The exact mechanisms are still being mapped, but the research in animal models is extensive.

Skincare peptides like Matrixyl and GHK-Cu signal fibroblasts in the skin to increase production of collagen, elastin, and other structural proteins. Neurotransmitter-inhibiting peptides like Argireline reduce muscle contractions that cause expression wrinkles.

The specificity of peptide action is what makes them attractive as therapeutics. A well-designed peptide can target a specific receptor or pathway without the broad systemic effects that many conventional drugs produce.

The Major Categories of Therapeutic Peptides

Peptide therapy spans a broad range of applications. Here are the main categories you will encounter:

Growth Hormone Peptides (GH Secretagogues)

These peptides stimulate your body's own production of growth hormone rather than injecting synthetic growth hormone directly. They include:

GHRH analogs: Sermorelin, CJC-1295 (with and without DAC), tesamorelin
Growth hormone-releasing peptides (GHRPs): GHRP-2, GHRP-6, ipamorelin, hexarelin
Growth hormone secretagogues: MK-677 (ibutamoren — technically not a peptide but an oral GH secretagogue)

Tesamorelin is the only GHRH analog with full FDA approval, specifically for HIV-associated lipodystrophy. The others are available through compounding pharmacies (where legal) or are used in research settings.

Metabolic and Weight-Loss Peptides

The GLP-1 receptor agonist revolution has transformed this category:

Semaglutide (Ozempic for diabetes, Wegovy for weight loss) — FDA-approved
Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) — FDA-approved dual GIP/GLP-1 agonist
Liraglutide (Victoza for diabetes, Saxenda for weight loss) — FDA-approved
AOD-9604 — A fragment of human growth hormone studied for fat loss, now prohibited from compounding

The STEP clinical trials for semaglutide showed average weight loss of 14.9% of body weight over 68 weeks. Tirzepatide's SURMOUNT-1 trial reported up to 22.5% body weight reduction at the highest dose over 72 weeks.

Tissue Repair and Healing Peptides

BPC-157 (Body Protection Compound-157) — Derived from a protein in gastric juice; studied extensively in animal models for tendon healing, gut repair, and anti-inflammatory effects. Currently prohibited from compounding by the FDA.
TB-500 (Thymosin Beta-4) — Studied for wound healing and tissue regeneration. Also prohibited from compounding.
GHK-Cu (copper peptide) — Available both as an injectable and in topical skincare. Promotes wound healing and collagen synthesis.

Immune-Modulating Peptides

Thymosin Alpha-1 (Zadaxin) — Approved in over 30 countries (not in the US) for hepatitis B and C, and as an immune adjuvant. Available through compounding in the US.
LL-37 — An antimicrobial peptide being studied for infections and immune regulation.
KPV — A tripeptide fragment of alpha-melanocyte-stimulating hormone with anti-inflammatory properties.

Cognitive and Neuroprotective Peptides

Semax — A synthetic fragment of ACTH, approved in Russia as a nootropic and neuroprotective agent.
Selank — A synthetic peptide analog of tuftsin, approved in Russia for anxiety and cognitive support.
Dihexa — A preclinical peptide studied for cognitive improvement; limited human data.

Sexual Health Peptides

PT-141 (bremelanotide/Vyleesi) — FDA-approved for hypoactive sexual desire disorder in premenopausal women. Works on melanocortin receptors in the brain rather than on blood vessels.

Skincare Peptides (Topical)

These are applied to the skin rather than injected:

Matrixyl and Matrixyl 3000 — Collagen-stimulating signal peptides
Argireline and SNAP-8 — Muscle-relaxing peptides for expression lines
GHK-Cu — Copper peptide for regeneration and repair

For a full breakdown of skincare peptides, see our guide on how to build a peptide skincare routine.

FDA-Approved Peptides: What is Already Mainstream

Peptide therapy is not fringe medicine. Since insulin was first used therapeutically in 1921, the FDA has approved approximately 100 peptide drugs. Between 2016 and 2024, 34 new peptide drugs received FDA approval — reflecting the growing importance of peptides in mainstream medicine.

Here are some of the most significant FDA-approved peptides:

Peptide	Brand Name(s)	Approved For	Year
Insulin (various)	Humalog, Lantus, Novolog	Diabetes	1921+
Semaglutide	Ozempic, Wegovy, Rybelsus	Type 2 diabetes, obesity	2017/2021
Tirzepatide	Mounjaro, Zepbound	Type 2 diabetes, obesity	2022/2023
Liraglutide	Victoza, Saxenda	Type 2 diabetes, obesity	2010/2014
Exenatide	Byetta, Bydureon	Type 2 diabetes	2005
Tesamorelin	Egrifta	HIV lipodystrophy	2010
Bremelanotide (PT-141)	Vyleesi	Hypoactive sexual desire	2019
Leuprolide	Lupron	Prostate cancer, endometriosis	1985
Octreotide	Sandostatin	Acromegaly, carcinoid tumors	1988
Elamipretide	(recently approved)	Barth syndrome	2025

If a doctor prescribes you one of these, you are receiving a thoroughly tested, FDA-regulated pharmaceutical with large-scale clinical trial data behind it.

Compounded Peptides: The Gray Zone

Compounding pharmacies prepare custom medications tailored to individual patients. A doctor writes a prescription, and a compounding pharmacy mixes the specific peptide at the prescribed dose and concentration. This fills a legitimate medical need when commercial formulations do not fit a patient's requirements.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies can prepare peptides that meet certain criteria:

The peptide must be either FDA-approved, have a USP monograph, appear on the FDA's 503A Bulks List, or be placed in Category 1 (meaning no identified safety concerns) on the interim 503A Bulks List.
A valid patient-specific prescription must be in hand.
The pharmacy must be licensed and meet quality standards.

Many peptides currently sit in an interim evaluation period. The FDA has created three categories for bulk drug substances under review:

Category 1: Can be compounded; no identified safety concerns
Category 2: Significant safety concerns identified; prohibited from compounding
Category 3: Under active evaluation; interim enforcement may or may not apply

Some peptides in the evaluation pipeline are still compounded during the interim period because the FDA has stated it will not take enforcement action against them while evaluation is underway. But this is not the same as approval — it is a temporary regulatory gray zone.

Peptides That Are Prohibited from Compounding

The FDA has explicitly placed several popular peptides in Category 2, meaning they are prohibited from being compounded for human use:

BPC-157 — Despite extensive animal research on tissue healing, the FDA cites insufficient human safety data and concerns about uncharacterized impurities in compounded versions.
TB-500 (Thymosin Beta-4) — Promoted for wound healing, but FDA classifies it as a "Substance with Safety Concerns."
AOD-9604 — Studied as a fat-loss fragment of growth hormone, but FDA cites immunogenicity risks.

This does not mean these peptides are "banned" in every context. Research use continues in academic and clinical settings. But you cannot legally obtain them through a US compounding pharmacy for personal use as of 2025-2026. Companies selling these peptides labeled "for research use only" are not selling them for human administration, regardless of what online forums may suggest.

How Peptides Are Administered

Different peptides require different routes of administration. The method affects how much of the peptide reaches its target and how quickly it works.

Subcutaneous Injection

The most common method for therapeutic peptides. A small needle (typically 27-31 gauge) is inserted into the fat layer just beneath the skin — usually in the abdomen, thigh, or upper arm.

Semaglutide is injected subcutaneously once per week using a prefilled pen. Growth hormone peptides like CJC-1295/ipamorelin are typically injected subcutaneously once or twice daily.

Subcutaneous injection provides high bioavailability (the peptide goes directly into the bloodstream without being broken down by stomach acid) and steady absorption.

Intramuscular Injection

Some peptides are injected into muscle tissue for faster absorption. This route is used for BPC-157 (when injected near an injury site) and some growth hormone peptides. The technique requires slightly longer needles and more precise injection placement.

Oral Administration

Most peptides break down in stomach acid before they can be absorbed. But some have been engineered for oral use:

Semaglutide (Rybelsus) uses a salcaprozate sodium (SNAC) absorption booster to survive the GI tract. It must be taken on an empty stomach with minimal water — and even then, oral bioavailability is only about 1% compared to injectable.
BPC-157 has an oral form that research suggests may be effective for gastrointestinal conditions, though oral bioavailability for systemic effects is much lower than injection.

Topical Application

Skincare peptides like Matrixyl, Argireline, and GHK-Cu are applied directly to the skin. Penetration through the skin's outer layer (stratum corneum) is a challenge, which is why lipid modifications (like the "palmitoyl" prefix) and specialized delivery systems are used to improve absorption.

Nasal Spray

Some peptides — particularly cognitive peptides like semax and selank — are administered intranasally. The nasal mucosa is thin and highly vascularized, allowing relatively rapid absorption into the bloodstream.

Comparison of Administration Routes

Route	Bioavailability	Speed of Onset	Ease of Use	Common Peptides
Subcutaneous injection	High (>90%)	30-60 minutes	Moderate (requires training)	Semaglutide, CJC-1295, ipamorelin
Intramuscular injection	High	15-30 minutes	Moderate	BPC-157 (localized), some GHRPs
Oral	Low (1-10%)	30-120 minutes	Easy	Oral semaglutide, oral BPC-157
Topical	Variable	Hours	Easy	Matrixyl, Argireline, GHK-Cu
Nasal spray	Moderate (10-30%)	10-20 minutes	Easy	Semax, selank, oxytocin

Finding a Qualified Peptide Therapy Provider

This may be the most important section in this guide. The difference between safe peptide therapy and a dangerous gamble is the medical provider overseeing your treatment.

What to Look For

A licensed physician (MD or DO), nurse practitioner, or physician assistant. Peptide therapy should be prescribed and monitored by a licensed medical professional. Chiropractors, naturopaths without prescriptive authority, and "wellness coaches" cannot legally prescribe peptides in most states.

Experience with peptide therapy specifically. General practitioners may not be familiar with peptide dosing protocols, monitoring requirements, or current regulatory status. Look for providers in anti-aging medicine, functional medicine, sports medicine, or endocrinology who specifically list peptide therapy among their services.

Blood work before and during treatment. A responsible provider will order baseline blood panels before starting any peptide protocol and follow up with monitoring labs. For growth hormone peptides, this means IGF-1 levels, fasting glucose, insulin, and a complete metabolic panel at minimum. For GLP-1 agonists, HbA1c, kidney function, and thyroid markers should be tracked.

Peptides sourced from a licensed pharmacy. Your provider should obtain peptides from a licensed 503A or 503B compounding pharmacy — not from online research chemical suppliers. Ask where their peptides come from. If they cannot or will not tell you, that is a red flag.

Willingness to discuss risks honestly. A provider who promises peptides will cure everything with no side effects is not giving you the full picture. Every therapeutic intervention has trade-offs. Your provider should discuss them openly.

Where to Search

American Academy of Anti-Aging Medicine (A4M) — maintains a provider directory
Institute for Functional Medicine (IFM) — another searchable provider database
Seeds Scientific Research & Performance — a physician network focused on peptide protocols
Your state medical board — verify any provider's license before starting treatment

Red Flags

Peptides sold directly from a clinic without a prescription
Online "peptide clinics" operating through telehealth with a five-minute consultation and no blood work
Providers prescribing peptides the FDA has explicitly prohibited from compounding (BPC-157, TB-500) after the prohibition date
Claims that peptides are "supplements" that do not require medical oversight

What to Expect When Starting Peptide Therapy

The Initial Consultation

A thorough first visit should include:

Health history review — current medications, medical conditions, goals
Blood work — baseline labs relevant to the peptide you are considering
Physical exam — assessing overall health and suitability for therapy
Treatment plan — specific peptide(s), dose, frequency, duration, monitoring schedule
Injection training — if using an injectable peptide, your provider or their staff should teach you proper reconstitution, injection technique, and site rotation

The First Few Weeks

For growth hormone peptides (CJC-1295/ipamorelin, sermorelin):

Expect improved sleep quality within the first week — this is one of the earliest reported effects
Increased energy and recovery may emerge by week 2-3
Body composition changes (fat loss, lean mass gains) typically take 8-12 weeks
Full effects usually develop over 3-6 months

For GLP-1 agonists (semaglutide, tirzepatide):

Appetite reduction begins within the first few days
Nausea is the most common early side effect — usually mild to moderate, peaking in the first 2-4 weeks and improving as your body adjusts
Weight loss becomes measurable within 2-4 weeks
Dose is gradually titrated upward over several months to the maintenance level

For skincare peptides (topical):

Improved hydration and skin texture within 1-2 weeks
Visible wrinkle reduction begins at 4-8 weeks
Full collagen-remodeling effects take 12-24 weeks of consistent use

Realistic Timeline Summary

Peptide Category	First Noticeable Effects	Meaningful Results	Full Effects
Growth hormone peptides	1-2 weeks (sleep, recovery)	8-12 weeks (body composition)	3-6 months
GLP-1 agonists	3-7 days (appetite)	4-8 weeks (weight loss)	12-18 months
Healing peptides	1-2 weeks (pain/inflammation)	4-6 weeks (tissue repair)	8-12 weeks
Skincare peptides	1-2 weeks (texture)	4-8 weeks (fine lines)	12-24 weeks

Safety, Side Effects, and Realistic Expectations

Peptides are not without risks. Here is an honest accounting of what can go wrong.

Common Side Effects

Injection site reactions: Redness, swelling, or mild pain at the injection site. Affects 10-20% of users. Usually resolves within hours.
Nausea (GLP-1 agonists): The most commonly reported side effect of semaglutide and tirzepatide. Dose titration — starting low and increasing gradually — reduces severity.
Water retention (growth hormone peptides): Temporary bloating and joint stiffness can occur as growth hormone levels increase. Usually resolves within 2-4 weeks.
Headache: Common in the first week with many peptide types. Usually transient.
Flushing (PT-141): Bremelanotide can cause temporary facial flushing and nausea.

Serious Concerns

Contamination risk with unregulated sources: FDA testing of online and compounded peptides has found that up to 40% contained incorrect dosages or undeclared ingredients. This is the single biggest safety risk in peptide therapy — not the peptides themselves, but the quality of what you are actually injecting.
Thyroid cancer risk (GLP-1 agonists): Semaglutide and tirzepatide carry an FDA black box warning about medullary thyroid carcinoma observed in rodent studies. The risk in humans has not been confirmed, but these drugs are contraindicated in people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.
Pancreatitis (GLP-1 agonists): Rare but documented. Seek immediate medical attention if you experience severe, persistent abdominal pain.
Tumor growth promotion (growth hormone peptides): Growth hormone can promote the growth of existing tumors. Anyone with active cancer or a recent cancer history should not use GH-stimulating peptides without explicit oncologist clearance.

What Peptide Therapy Cannot Do

No peptide will:

Replace proper nutrition, exercise, and sleep
Reverse decades of damage in a few weeks
Work safely without medical monitoring
Bypass the need for blood work and health screening

Peptide therapy is a tool — one that can be powerful when used correctly and dangerous when used recklessly.

Peptide Storage and Handling Basics

Proper storage is not optional. Peptides are fragile molecules that degrade when exposed to heat, light, moisture, or repeated temperature fluctuations.

Lyophilized (Freeze-Dried) Peptides

Store at -20 degrees C for long-term preservation (up to 1 year)
Can be stored at 2-8 degrees C (standard refrigerator) for short-term use (weeks to months)
Stable at room temperature for several days to a few weeks, but long-term room temperature storage is not recommended

Reconstituted (Mixed) Peptides

Once a lyophilized peptide is reconstituted with bacteriostatic water or saline:

Store at 2-8 degrees C (refrigerator)
Use within 1-2 weeks at refrigerator temperature
Never freeze reconstituted peptides — the freeze-thaw cycle damages peptide structure
Protect from light — store in amber vials or opaque containers

Handling Rules

Allow refrigerated vials to reach room temperature before opening to prevent condensation
Use sterile technique when reconstituting — wipe vial tops with alcohol swabs
Rotate injection sites to prevent lipodystrophy (tissue changes from repeated injections in the same spot)
Dispose of needles and syringes in a proper sharps container

The Legal Status of Peptides in 2025-2026

The regulatory situation for peptides is complicated and actively evolving. Here is the current state:

Fully Legal (FDA-Approved Prescription Drugs)

Semaglutide, tirzepatide, liraglutide, tesamorelin, bremelanotide (PT-141), insulin, octreotide, leuprolide, and dozens of other peptides are fully FDA-approved and legally prescribed every day.

Legal Through Compounding (With Prescription)

Peptides on the FDA's 503A Bulks List or in Category 1 of the interim evaluation can be legally compounded with a valid prescription. This includes some growth hormone peptides, thymosin alpha-1, and others that meet compounding requirements.

Prohibited from Compounding (Category 2)

BPC-157, TB-500, and AOD-9604 are explicitly prohibited from compounding for human use due to safety concerns identified by the FDA. However, some clinics and pharmacies continued to compound these peptides during interim evaluation periods, and enforcement has been inconsistent.

Research Use Only

Many peptides are sold legally as research chemicals — labeled "not for human consumption" or "for research use only." Purchasing them is legal. Using them on yourself is a legally gray area. The quality, purity, and accuracy of these products is unregulated.

Off-Label Use is Legal

Doctors can legally prescribe FDA-approved peptides for off-label purposes — using them for conditions other than their approved indication. This is standard medical practice. For example, semaglutide is sometimes prescribed off-label for PCOS or NASH, not just diabetes and obesity. Off-label use is legal when based on clinical judgment and evidence-based practice.

International Variation

Peptide legality varies dramatically by country. Thymosin alpha-1 is approved in over 30 countries but not in the US. Some peptides available over-the-counter in some nations are prescription-only or banned in others. If you travel with peptides, check the regulations of your destination country. (See our guide to traveling with peptides for details.)

Common Myths and Misconceptions

Myth: "Peptides are steroids." Peptides are not anabolic steroids. They are amino acid chains that signal biological processes. Growth hormone peptides increase your body's own GH production; they do not introduce synthetic testosterone or other androgens.

Myth: "All peptides are banned." Roughly 100 peptides are FDA-approved prescription drugs. Many more are legally compounded with a prescription. Only a handful are specifically prohibited from compounding.

Myth: "You do not need a doctor for peptide therapy." You absolutely do. The risks of contaminated, misdosed, or inappropriate peptide use without medical oversight are serious. A provider who orders baseline blood work, monitors your response, and adjusts dosing is not optional — it is the difference between therapy and experimentation.

Myth: "Peptides work immediately." Most peptide therapies require weeks to months to produce meaningful results. Growth hormone peptides take 3-6 months for full body composition effects. GLP-1 agonists are dose-titrated over months. Topical peptides need 8-24 weeks for collagen remodeling.

Myth: "More is better." Higher doses of peptides do not necessarily produce better results and can increase side effects. Growth hormone peptides at excessive doses can cause insulin resistance, joint pain, and carpal tunnel syndrome. The goal is to find the minimum effective dose.

Frequently Asked Questions

How much does peptide therapy cost?

Costs vary widely. FDA-approved GLP-1 agonists like Ozempic or Wegovy can cost $800-$1,500 per month without insurance. Compounded peptides from licensed pharmacies typically run $100-$400 per month depending on the peptide and dosing. Provider consultation fees range from $100-$500 for initial visits. Blood work adds $100-$500 depending on the panel.

Is peptide therapy covered by insurance?

FDA-approved peptides prescribed for their approved indications (e.g., semaglutide for type 2 diabetes) are often covered by insurance, though coverage varies by plan. Compounded peptides and off-label use are rarely covered.

Can I take multiple peptides at the same time?

Yes, under medical guidance. Stacking protocols — such as CJC-1295 with ipamorelin, or combining growth hormone peptides with a tissue-repair peptide — are common in clinical practice. Your provider should manage the combination to avoid interactions or excessive stimulation. See our peptide stacking guide for more information.

How long do I need to stay on peptide therapy?

It depends on the peptide and your goals. GLP-1 agonists for weight management may be prescribed long-term. Growth hormone peptide protocols often run 3-6 months with breaks between cycles. Some peptides like thymosin alpha-1 for immune support may be used seasonally or as needed.

Are peptides safe for women?

Yes, with appropriate medical supervision. PT-141 (Vyleesi) was specifically approved for women. Many women use growth hormone peptides, GLP-1 agonists, and skincare peptides safely. Certain peptides should be avoided during pregnancy and breastfeeding — always disclose your reproductive status to your provider.

The Bottom Line

Peptide therapy is real medicine with real science behind it. Some peptides — like semaglutide, tirzepatide, and tesamorelin — are FDA-approved, backed by large clinical trials, and prescribed by doctors every day. Others occupy a more uncertain regulatory space, with strong preclinical data but limited human studies.

The safest path forward has three requirements. First, work with a licensed medical provider who specializes in peptide therapy and orders appropriate lab work. Second, use peptides sourced from licensed compounding pharmacies — never from unregulated online suppliers. Third, set realistic expectations. Peptides are powerful tools, but they work gradually, require consistency, and carry real side effects that need monitoring.

If you are interested in starting, find a qualified provider, get your baseline blood work done, and have an honest conversation about your goals and health history. That is the responsible way into peptide therapy — and the one most likely to produce the results you are looking for.

References

FDA. "Substances with Safety Concerns — Bulk Drug Substance Evaluation." https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a
Frier Levitt. "Regulatory Status of Peptide Compounding in 2025." https://www.frierlevitt.com/articles/regulatory-status-of-peptide-compounding-in-2025/
Holt Law. "Deep Dive: Regulatory Status of Popular Compounded Peptides." https://djholtlaw.com/deep-dive-regulatory-status-of-popular-compounded-peptides/
Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." New England Journal of Medicine. 2021;384:989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)." New England Journal of Medicine. 2022;387:205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
PMC. "2024 FDA TIDES (Peptides and Oligonucleotides) Harvest." Pharmaceuticals. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11945313/
THPdb2. "Database of FDA-Approved Therapeutic Peptides and Proteins." Drug Discovery Today. 2024. https://www.sciencedirect.com/science/article/abs/pii/S1359644624001727
MBI. "Peptides in Limbo: The Legal and Ethical Crossroads of America's Bioregulator Market." https://www.medbioinstitute.com/resources/topics/peptides-in-limbo-the-legal-and-ethical-crossroads-of-americas-booming-bioregulator-market
Advanced Practitioners Network. "Peptide Therapy in 2025: Legal Updates, FDA Bans, and Safe Prescribing for Providers." https://www.advancedpractitionersnetwork.com/training-articles/peptide-therapy-in-2025-legal-updates-fda-bans-and-safe-prescribing-for-providers
Innerbody Research. "Beginner's Guide to Peptide Therapy [2026]." https://www.innerbody.com/beginners-guide-to-peptide-therapy

Table of Contents